Ferumoxytol

Generic Name
Ferumoxytol
Brand Names
Feraheme
Drug Type
Small Molecule
Chemical Formula
Fe3O4
CAS Number
722492-56-0
Unique Ingredient Identifier
G6N3J05W84
Background

Ferumoxytol is an intravenously administered iron preparation indicated in the EU and the US for the treatment of iron deficiency anemia in adult patients with chronic kidney disease (CKD) .
...

Indication

This drug is indicated for the treatment of iron deficiency anemia in adult patients who have experienced intolerance to oral iron or have experienced an unsatisfactory response to oral iron or

who have chronic kidney disease (CKD) .

Associated Conditions
Iron Deficiency Anemia (IDA)
Associated Therapies
-
Clinical Trials
Related News

Assessing Dynamic Magnetic Resonance (MR) Imaging in Patients With Recurrent High Grade Glioma Receiving Chemotherapy

Phase 1
Terminated
Conditions
Brain Neoplasms
Interventions
Drug: Ferumoxytol
First Posted Date
2008-10-08
Last Posted Date
2017-04-21
Lead Sponsor
OHSU Knight Cancer Institute
Target Recruit Count
6
Registration Number
NCT00769093
Locations
🇺🇸

Oregon Health & Science University, Portland, Oregon, United States

Magnetic Resonance Angiography for Peripheral Arterial Disease (PAD)

First Posted Date
2008-07-01
Last Posted Date
2019-04-26
Lead Sponsor
AMAG Pharmaceuticals, Inc.
Target Recruit Count
108
Registration Number
NCT00707876

MRI Study With Ferumoxytol in Assessing Early Response in Patients With Glioblastoma Multiforme Receiving Temozolomide and Radiation Therapy

First Posted Date
2008-04-17
Last Posted Date
2017-05-16
Lead Sponsor
OHSU Knight Cancer Institute
Target Recruit Count
14
Registration Number
NCT00660543
Locations
🇺🇸

OHSU Knight Cancer Institute, Portland, Oregon, United States

MR, Histologic And EM Imaging Of Intravenous Ferumoxytol In Central Nervous System (CNS) Inflammation

Phase 2
Terminated
Conditions
Nervous System Diseases
Diagnostic Imaging
Interventions
Drug: Ferumoxytol
First Posted Date
2008-04-16
Last Posted Date
2024-01-30
Lead Sponsor
Oregon Health and Science University
Target Recruit Count
255
Registration Number
NCT00659776
Locations
🇺🇸

Oregon Health & Science University, Portland, Oregon, United States

Ferumoxytol- and Gadolinium-Labeled MRI in Measuring Tumors Before or After Treatment in Patients With Primary or Metastatic Brain Tumors

First Posted Date
2008-04-16
Last Posted Date
2023-09-07
Lead Sponsor
OHSU Knight Cancer Institute
Target Recruit Count
40
Registration Number
NCT00659126
Locations
🇺🇸

OHSU Knight Cancer Institute, Portland, Oregon, United States

A Study of the Electrocardiogram Effects and Pharmacokinetics of Ferumoxytol in Healthy Men and Women

Phase 1
Completed
Conditions
Anemia
First Posted Date
2006-08-04
Last Posted Date
2022-04-04
Lead Sponsor
AMAG Pharmaceuticals, Inc.
Target Recruit Count
174
Registration Number
NCT00360425

Ferumoxytol in Improving MR Imaging in Patients With High-Grade Brain Tumors or Cerebral Metastases

First Posted Date
2005-02-08
Last Posted Date
2022-06-09
Lead Sponsor
OHSU Knight Cancer Institute
Target Recruit Count
155
Registration Number
NCT00103038
Locations
🇺🇸

OHSU Knight Cancer Institute, Portland, Oregon, United States

Magnetic Resonance Imaging of Lymph Nodes Using Ferumoxytol in Patients With Primary Prostate or Breast Cancer

Completed
Conditions
Breast Cancer
Prostate Cancer
First Posted Date
2004-07-12
Last Posted Date
2013-05-14
Lead Sponsor
Massachusetts General Hospital
Target Recruit Count
14
Registration Number
NCT00087347
Locations
🇺🇸

Massachusetts General Hospital Cancer Center, Boston, Massachusetts, United States

© Copyright 2024. All Rights Reserved by MedPath
HomeTerms & ConditionsPrivacy Policy